Suspected unexpected adverse effect of sugammadex: hypotension.
Merja
M
Kokki
Mohamed
M
Ali
Matti
M
Turunen
Hannu
H
Kokki
D000328:Adult; D018685:Anesthetics, Inhalation / Q000037:antagonists & inhibitors*; D004359:Drug Therapy, Combination; D005039:Etilefrine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007022:Hypotension / Q000139:chemically induced* / Q000188:drug therapy / Q000503:physiopathology; D009466:Neuromuscular Blocking Agents / Q000037:antagonists & inhibitors*; D010656:Phenylephrine / Q000627:therapeutic use; D012720:Severity of Illness Index; D000077122:Sugammadex; D016896:Treatment Outcome; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D047408:gamma-Cyclodextrins / Q000009:adverse effects*
D018685:Anesthetics, Inhalation; D009466:Neuromuscular Blocking Agents; D014662:Vasoconstrictor Agents; D047408:gamma-Cyclodextrins; D010656:Phenylephrine; D000077122:Sugammadex; D005039:Etilefrine